EGFR and myotonic dystrophy type 1: These data allow us to conclude that EGF-activated EGFR is able to signal from endosomes and its delay in the endocytic trafficking does not affect the downstream (AKT and ERK1/2) signaling pathways in DM1 cells, but highlights a difference in p-AKT levels between cell lines.